Skip to main content

Table 2 Biological profiles of cases that underwent re-biopsy by EBUS procedures (N = 53)

From: Re-biopsy by endobronchial ultrasound procedures for mutation analysis of non-small cell lung cancer after EGFR tyrosine kinase inhibitor treatment

Initial EGFR mutation profile

 

EGFR mutation profile on re-biopsy

 

Del19

30

Del19 alone

8

Del19 + T790M

16

Re-biopsy failure

6

L858R

22

L858R alone

11

L858R + T790M

6

Re-biopsy failure

5

L816Q

1

L816Q alone

1

  1. Data are presented as number
  2. EBUS endobronchial ultrasound, EGFR epidermal growth factor receptor